Week In Review: 3 China Biopharmas Announce Plans For Shanghai/Hong Kong IPOs

Chengdu New Radiomedicine Technology raised $14 million in a funding round led by BTG Asia, a subsidiary of London healthcare investor BTG plc. Shanghai’s Abbisko Therapeutics acquired Greater …
( read original story …)

---